Ekkehard Eigendorff

Molecular-defined clonal evolution in patients with chronic myeloid leukemia independent of the BCR-ABL status

Mathias Schmidt, Jenny Rinke, Vivien Schäfer et al. · Leukemia · 2014 · 141 citations

Medicine, Hematology, Molecular Biology +15

Cost-effectiveness of Tyrosine Kinase Inhibitor Treatment Strategies for Chronic Myeloid Leukemia in Chronic Phase After Generic Entry of Imatinib in the United States

William V. Padula, Richard A. Larson, Stacie B. Dusetzina et al. · JNCI Journal of the National Cancer Institute · 2016 · 126 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacotherapy +17

Expression of the CTLA-4 ligand CD86 on plasmacytoid dendritic cells (pDC) predicts risk of disease recurrence after treatment discontinuation in CML

Christin Schütz, Sabrina Inselmann, S Sausslele et al. · Leukemia · 2017 · 106 citations

Life Sciences, Hematology, Immunology +17

Interferon alpha 2 maintenance therapy may enable high rates of treatment discontinuation in chronic myeloid leukemia

Andreas Burchert, Ekkehard Eigendorff, Martin C. Müller et al. · Leukemia · 2015 · 62 citations

Medicine, Oncology, Pharmacotherapy +11

Which is the most suitable lymph node predictor for overall survival after primary surgery of head and neck cancer: pN, the number or the ratio of positive lymph nodes, or log odds?

Mehmet Metin Yildiz, Iver Petersen, Ekkehard Eigendorff et al. · Journal of Cancer Research and Clinical Oncology · 2015 · 51 citations · Full text

Medicine, Oncology, Surgery +17